Biotechnology is at the heart of a fast-growing new sector of the U.S. economy, and as the industry expands, it has become a focal point of many local, regional, and state economic development strategies. This report provides an analysis of biotechnology activity in the 51 largest U.S. metropolitan areas and finds that the industry is heavily concentrated in nine regions. These nine areas excel because they possess two key ingredients necessary for biotech growth: strong research, and the ability to convert that research into commercial activity. By comparing the 51 metro areas on their research and commercialization capacities, this report can help inform regions seeking to capture a share of the nation’s biotechnology growth.
Full Report Divided Into Sections:
Section 1 | Section 2 | Section 3 | Section 4 | Section 5
Regional Profiles
Boston | Los Angeles | New York | Philadelphia | Raleigh-Durham | San Diego | San Francisco | Seattle Washington-Baltimore
PowerPoint
“Signs of Life: The Growth of
Biotechnology Centers in the U.S.“
Presented by Joseph Cortright to the Biotech Industry of the Washington Metropolitan Area, June 11, 2002
The Brookings Institution is committed to quality, independence, and impact.
We are supported by a diverse array of funders. In line with our values and policies, each Brookings publication represents the sole views of its author(s).
